Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Characterizing high-affinity antigen/antibody complexes by kinetic- and equilibrium-based methods.

Andrew W Drake1, David G Myszka, Scott L Klakamp

  • 1Abgenix, Inc., 6701 Kaiser Drive, Fremont, CA 94555, USA.

Analytical Biochemistry
|April 15, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CHS-114: An Afucosylated Anti-CCR8 Monoclonal Antibody that Selectively Depletes Intratumoral Treg Cells and Induces Antitumor Immune Responses.

Molecular cancer therapeutics·2025
Same author

A novel label-free method to determine equilibrium dissociation constants of antibodies binding to cell surface proteins.

Scientific reports·2025
Same author

Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cells.

Cancer immunology, immunotherapy : CII·2024
Same author

Biophysical characterization of PVR family interactions and therapeutic antibody recognition to TIGIT.

mAbs·2023
Same author

Miscalculating Equilibrium Constants for Multivalent Protein Complexes: Site-Binding Concentration or Protein Molecular Concentration?

Journal of pharmaceutical sciences·2021
Same author

Development of a Model Protein Interaction Pair as a Benchmarking Tool for the Quantitative Analysis of 2-Site Protein-Protein Interactions.

Journal of biomolecular techniques : JBT·2015

This study validates Biacore and KinExA for characterizing high-affinity antigen/antibody interactions. Both methods accurately determined kinetic rate constants and affinities, confirming their suitability for complex biological analyses.

Area of Science:

  • Biophysics
  • Immunology
  • Biochemistry

Background:

  • Characterizing high-affinity antigen/antibody interactions is crucial in immunology and drug development.
  • Accurate kinetic and thermodynamic data are essential for understanding molecular binding events.

Purpose of the Study:

  • To kinetically and thermodynamically characterize high-affinity antigen/antibody complexes using Biacore and KinExA.
  • To compare the performance and suitability of solution-phase (KinExA) and solid-phase (Biacore) methodologies for high-affinity interactions.

Main Methods:

  • Utilized Biacore (surface plasmon resonance) and KinExA (chemiluminescence immunoassay) for interaction analysis.
  • Performed 3-5 independent experiments on three distinct antigen/antibody complexes with nanomolar to picomolar affinities.

Related Experiment Videos

  • Monitored dissociation phases over extended periods (up to 4h for Biacore, 35h for KinExA) to capture slow dissociation events.

    • Main Results:

    • Biacore successfully measured dissociation rate constants (kd) around 1 x 10(-5)s(-1).
    • KinExA required equilibration times up to 35 hours to accurately characterize high-affinity interactions.
    • Both methods yielded comparable kinetic rate constants and affinity measurements.

    Conclusions:

    • Biacore and KinExA are validated for characterizing extremely high-affinity antigen/antibody interactions.
    • Solution-phase and solid-phase methodologies provide consistent results for affinity and kinetic characterization.
    • These findings support the use of both interaction technologies in biophysical studies.